PMD Device Solutions AB (Publ) Postpones the Annual General Meeting
STOCKHOLM, SWEDEN / ACCESSWIRE / May 27, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions AB (publ) cancels the...
Month: May 2024
James Anderson and Life Beyond Barriers, LLC Provide Update on Holdings of MyndTec Inc.
Detroit, Michigan--(Newsfile Corp. - May 27, 2024) - James Anderson and Life Beyond Barriers, LLC (together, the "Investor") filed an...
MyndTec Inc. Completes Fifth Tranche of Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - May 27, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging player in...
Red Light Holland Completes First Phase of Natural Psilocybin Extraction with PharmAla, Initiates Optimization Process
Toronto, Ontario--(Newsfile Corp. - May 27, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
IRLAB Appoints Kristina Torfgård as New CEO
GOTHENBURG, SE / ACCESSWIRE / May 27, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden. May 27, 2024 - IRLAB Therapeutics...
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
72-week data consistent with disease modification in IgAN, selected as a best-ranked abstract;Rapid and sustained improvements in hematuria over 36...
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company’s IgA nephropathy (IgAN) portfolio
In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine)...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo
Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label...
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
MELVILLE, N.Y., May 24, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company...
Halo Dental Technologies Showcase Their Digital Mirror at Montreal-based JDIQ Annual Conference
At the largest bilingual dental convention in North America, Halo will showcase the first-of-its-kind digital dental mirror at its home-city...
Cosmo Pharmaceuticals’ Shareholders Approve All Agenda Items at Annual General Meeting
Dublin, Ireland--(Newsfile Corp. - May 24, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced that its...
FSD Pharma Provides Corporate Update
TORONTO, ON / ACCESSWIRE / May 24, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...
NLS Pharmaceutics Announces Receipt of Additional Staff Delisting Determination from Nasdaq
ZÜRICH, SWITZERLAND / ACCESSWIRE / May 24, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-Q
CHICAGO, IL / ACCESSWIRE / May 24, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Asia Green Biotechnology Corp. Announces Filing of Financial Statements on SEDAR
CALGARY, AB / ACCESSWIRE / May 24, 2024 / Asia Green Biotechnology Corp. ("Asia Green" or the "Company") (CSE:ASIA) announces...
KERATO Leads with Permanent Eye Color Change: A Milestone in Cosmetic Safety
NEW YORK, NY / ACCESSWIRE / May 24, 2024 / KERATO, the pioneering leader in permanent eye color change, is...
Meet the Amazon Women of the Ivory Coast Who Are Revolutionizing Finance
NORTHAMPTON, MA / ACCESSWIRE / May 24, 2024 / CAREThe "Amazons" of the Kingdom of Dahomey were known for their...
On May 24th, 2024, the Florida Spine Institute and Wellness Center, Leaders in the Treatment of Spine and Musculoskeletal Disorders, announced the publication of, Best Selling Author, Dr. Francisco M. Torres, M.D.’s new book, “Beyond Diagnosis: Perspective in Medicine and The Human Experience.”
The book is a collection of dozens of his essays about the human experience of practicing medicine. It covers various...
TruBridge Announces Participation in the Stifel Cross Sector Insight Conference
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced that management will participate in the Stifel Cross Sector...
GRM Information Management to Attend the 2024 MUSE Inspire Conference
Visit GRM Information Management in Booth #125 at the 2024 MUSE Inspire Conference in Denver, CO May 28-31JERSEY CITY, N.J.--(BUSINESS...